Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock has filed 8 SEC Form 4 filings (26 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| MPLT | Chief Medical Officer | Sale | 28,455 | $1.0M | Jul 18 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 15,047 | $553K | Jul 18 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 3,656 | $139K | Jul 18 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 4,438 | $127K | May 12 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 15,652 | $438K | May 7 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 10,576 | $298K | May 7 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 24,052 | $692K | May 7 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 2,044 | $55K | Apr 17 | SEC ↗ | |
| MPLT | Chief Medical Officer | Sale | 1,169 | $32K | Apr 17 | SEC ↗ |